RARafael Alvarez

Rafael Alvarez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rafael Alvarez has a total of 60 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Sleeve gastrectomy morphology and long-term weight-loss and gastroesophageal reflux disease outcomes

    by Rafael Alvarez, Joseph Youssef, Jonathan Zadeh, Anuja Sarode, Richard Barger, Mujjahid Abbas, Leena Khaitan

    Background The relationship between sleeve gastrectomy (SG) morphology and long-term weight-loss and gastroesophageal reflux disease (GERD) outcomes is unknown. Methods All patients (n = 268) undergoing SG performed by 3 surgeons at a single academic institution from January 1, 2010 to December 31, 2012 were included. Long-term weight-loss and GERD outcomes were available for 90 patients which were incorporated in analyses. SG morphology was determined from postoperative day 1 upper gastrointestinal series (UGIS) available from 50 patients. Images were independently categorized using previously published methodology as Dumbbell (38%), Lower Pouch (22%), Tubular (26%), or Upper Pouch (14%) by Radiologist and Surgeon. Radiologist categorization was used when disagreement occurred (8%). Univariable analyses were conducted to explore potential associations between SG morphology, weight loss, and GERD outcomes. Results Follow-up was 8.2 ± 0.9 years. Population characteristics included age of 45.1 ± 10.8 years, female sex in 83.3%, and hiatal hernia repair (HHR) performed at index SG in 17.8%. Surgeons did not preferentially achieve a specific SG morphology. Changes from preoperative obesity and associated diseases comprised body mass index (BMI) (49.5 ± 7.6 vs. 39.2 ± 9.4 kg/m2; p < 0.0001), diabetes mellitus (30.0 vs. 12.2%; p = 0.0006), hypertension (70.0 vs. 54.4%; p = 0.0028), hyperlipidemia (42.2 vs. 24.2%;p = 0.0017), obstructive sleep apnea (41.1 vs. 15.6%; p < 0.0001), osteoarthritis (48.9 vs. 13.3%; p < 0.0001), back pain (46.5 vs. 28.9%; p = 0.0035), and medications (4.8 ± 3.3 vs. 3.7 ± 3.5; p < 0.0001). Dumbbell SG morphology was associated with lesser reduction in BMI at follow-up (-−6.8 ± 7.2 vs. −12.4 ± 8.3 kg/m2; p = 0.0196) while greater BMI change was appreciated with Lower Pouch SG shape (−16.9 ± 9.9 vs. −8.4 ± 6.8 kg/m2; p = 0.0017). GERD was more prevalent at follow-up than baseline (67.8 vs. 47.8%; p < 0.0001). GERD-specific outcomes included de novo (51.1%), persistent (27.9%), worsened (58.1%), and resolved (14.0%) disease. Ten patients underwent reoperation for refractory GERD with SG morphology corresponding to Dumbbell (n = 5) and Upper Pouch (n = 1) for those with available UGIS. Univariable analyses showed that patients with GERD experienced a larger reduction in BMI compared with patients without GERD (−11.8 ± 7.7 vs. −7.0 ± 5.1 kg/m2; p = 0.0007). Patient age, surgeon, morphology category, and whether a HHR was done at index SG were not associated with the presence of any, de novo, or worsened GERD. Female sex was associated with worsened GERD (96.0 vs. 4.0%; p = 0.0455). Type of calibration device, distance from staple line to pylorus, and whether staple line reinforcement was used were not associated with SG morphology classification. Conclusion This is the first study assessing the impact of SG morphology on long-term weight loss and GERD. Our data suggest an association between SG morphology and long-term weight loss but not with GERD outcomes. Current technical standards may be limited in reproducing the same SG morphology. This information may help guide the technical optimization and standardization of SG. Graphical abstract Surgeons did not favor a specific SG morphology (1). Our results signal to a relationship between radiographic assessment of SG morphology and long-term weight-loss outcomes with Dumbbell classification correlated with lesser reduction in BMI (2a) and Lower Pouch morphology associated with superior weight loss (2b). SG, sleeve gastrectomy; BMI, body mass index.


  • Independent association of preoperative Hill grade with gastroesophageal reflux disease 2 years after sleeve gastrectomy

    by Rafael Alvarez, Brandon L. Ward, Tianqi Xiao, Jonathan Zadeh, Anuja Sarode, Leena Khaitan, Mujjahid Abbas


  • Factors associated with completion of patient surveys 1 year after bariatric surgery

    by Rafael Alvarez, Amanda Stricklen, Colleen M. Buda, Rachel Ross, Aaron J. Bonham, Arthur M. Carlin, Oliver A. Varban, Amir A. Ghaferi, Jonathan F. Finks


  • Factors Associated With Long Wait Times for Bariatric Surgery

    by Rafael Alvarez, Aaron J. Bonham, Colleen M. Pa-C Buda, Arthur M. Carlin, Amir A. Ghaferi, Oliver A. Varban

    Background: Despite its proven safety and efficacy, bariatric surgery is an underutilized therapy for severe obesity. Wait times for surgery are largely unexplored in the United States and may impact access to care. Objective: To determine the amount of time between initial bariatric surgery clinic visit and operative date and identify factors associated with longer wait times. Methods: A statewide clinical data registry was queried from 2006 to 2016 and 60,791 patients undergoing primary bariatric surgery were identified. Demographics, comorbidities, 30-day complications, and 1-year patient-reported outcomes were compared between shortest and longest wait time quartiles. Analyses were performed using Chi-square, t-test, and logistic regression. Results: Median wait times for bariatric surgery increased from 86 to 159 days during the study period. Median wait times were ≤67 days for the shortest wait time quartile and ≥204 days for the longest wait time quartile. Factors independently associated with longer wait times included Medicaid insurance [odds ratio (OR) 3.02; 95% confidence interval (CI): 2.58–3.53], sleep apnea (OR 1.49; 95% CI: 1.41–1.58), psychological disorder (OR 1.25; 95% CI: 1.18–1.32), hyperlipidemia (OR 1.21; 95% CI: 1.14–1.28), smoking history (OR 1.11; 95% CI: 1.05–1.17), and white race (OR 0.665; 95% CI: 0.614–0.720). Preoperative weight loss, risk adjusted complication rates, postoperative self-reported weight loss, and comorbidity remission were similar between groups. Conclusions: Over the past decade, eligible patients are experiencing longer wait times when pursuing bariatric surgery. Complex patients with Medicaid insurance are experiencing the longest delay despite similar outcomes and preoperative weight loss. Policies that delay surgery should be re-examined.


  • The Unconventional Role for Gastric Volume in the Response to Bariatric Surgery for Both Weight Loss and Glucose Lowering

    by Simon S. Evers, Alfor G. Lewis, Cindy Tong, Yikai Shao, Rafael Alvarez, Elika Ridelman, Bethany Grant, Randy J. Seeley

    The data shows that surgery-induced gastric volume reduction by excision, plication, or contraction of gastric tissue is related to increased gastric emptying rate and increased GLP-1 response. However, unlike others suggested, increased GLP-1 responses are not related to improved glucose tolerance. The data reveals that a threshold of >75% reduction of gastric volume is necessary to induce long-term sustained weight loss with accompanied improvements of glucose tolerance. This most likely requires excising gastric tissue. To study the relationship between the amount of surgery-induced gastric volume reduction and long-term weight loss and glucose tolerance. Vertical sleeve gastrectomy (VSG) has recently surpassed gastric bypass to become the most popular surgical intervention to induce sustained weight loss. Besides inducing significant weight loss, VSG also improves glucose tolerance. Although no clear correlation has been observed between the size of the residual stomach and sustained weight loss, this begs the question whether less aggressive gastric volume reduction may provide sufficient efficacy when weight loss is not the major goal of the surgical intervention. A series of strategies to reduce gastric volume were developed and tested in Long Evans male rats, namely: VSG, Fundal (F)-Resection, Gastric Sleeve Plication (GSP), Fundal-Plication, and Fundal-Constrained. All surgical interventions resulted in a reduction of gastric volume relative to sham, but none of the interventions were as effective as the VSG. Gastric volume was linearly correlated to increased gastric emptying rate as well as increased GLP-1 response. Overall, cumulative food intake was the strongest correlate to weight loss and was logarithmically related to gastric volume. Regression modeling revealed a nonlinear inverse relation between body weight reduction and gastric volume, confirming that VSG is the only effective long-term weight loss strategy among the experimental operations tested. The data suggest a minimum threshold volume of the residual stomach that is necessary to induce sustained weight loss. Although all gastric volume interventions increased the GLP-1 response, none of the interventions, except VSG, significantly improved glucose tolerance. In conclusion, if weight loss is the primary goal of surgical intervention, significant volume reduction is required, and this most likely requires excising gastric tissue.


  • Factors associated with bariatric surgery utilization among eligible candidates: who drops out?

    by Rafael Alvarez, Niki Matusko, Amanda L. Stricklen, Rachel Ross, Colleen M. Buda, Oliver A. Varban


  • Assessment of mammographic breast density after sleeve gastrectomy

    by Rafael Alvarez, Elika Ridelman, Natalie Rizk, Morgan S. White, Chuan Zhou, Heang-Ping Chan, Oliver A. Varban, Mark A. Helvie, Randy J. Seeley